Our 20-plus years of RNAi experience together with our validated mRNAi GOLD™ platform make us a
partner of choice for pharmaceutical companies looking to access the benefits of the siRNA and add
this revolutionary modality to their discovery pipeline. As pioneers in the design and development of
siRNAs (short interfering RNAs), Silence Therapeutics is advancing a new generation of medicines to
potentially address the needs of patients who have limited or inadequate treatment options.
Our mission is to use our technology to create a new generation of therapeutics which can improve
outcomes for patients and, in the process, build shareholder value.
We are developing a deep pipeline of innovative siRNAs based on our mRNAi GOLD™ platform for
diseases with a genetic basis. The depth and versatility of our liver-targeting technology gives us the
opportunity to address a wide range of conditions in virtually any therapeutic area.
Silence Therapeutics only accepts job applications through our official careers site at Silence-Therapeutics.com/Careers. If you’re contacted by someone claiming to represent Silence Therapeutics outside of these channels, please be cautious. Do not share personal or financial information unless you’re applying through our verified platforms. If you’re unsure about a message or job offer, feel free to contact us at HR@Silence-Therapeutics.com to ensure it’s legitimate.
Company Details
- Employees
- 101
- Founded
- -
- Address
- 72 Hammersmith Road, London,w14 8th,united Kingdom
- Phone
- 4402037009711
- in****@****ics.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- silence-therapeutics.com
- Keywords
- Biotechnology, RNA Interference, RNAi, siRNA.
- HQ
- London
Silence Therapeutics Plc Questions
Silence Therapeutics Plc's helpline number is 4402037009711
Silence Therapeutics Plc's website is silence-therapeutics.com
Silence Therapeutics Plc's LinkedIn profile is https://www.linkedin.com/company/silence-therapeutics-plc
Silence Therapeutics Plc has
101 employees.
View email and phone details for 101
employees at Silence Therapeutics Plc.
Silence Therapeutics Plc's industry is
Biotechnology Research
Silence Therapeutics Plc's top competitors are
Mina Therapeutics,
Achilles Therapeutics Plc,
Autolus Therapeutics,
Shield Therapeutics Plc,
Orchard Therapeutics - U.s.,
Alnylam Pharmaceuticals,
Adaptimmune,
Quell Therapeutics,
E-Therapeutics Plc,
Vertex Pharmaceuticals.
Silence Therapeutics Plc's support email address is info@silence-therapeutics.com
Silence Therapeutics Plc's categories are Biotechnology Research
Silence Therapeutics Plc's founding year is 1999
